Get started
Author

DeAnne F. Stolarik

Observed names: D. Stolarik, DeAnne F Stolarik, DeAnne Stolarik, Deanne F. Stolarik, Deanne Stolarik, Stolarik, D.F., Stolarik, DeAnne
OpenAlex ID: A5062433859
Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
2015 · Todd A. Hopkins, Yan Shi, et al. · Molecular Cancer Research · 271
Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport
2018 · Venecia Wilson, Xiaochun Lou, et al. · Journal of Controlled Release · 168
Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease
2021 · Matthew Rosebraugh, Eric A. Voight, et al. · Annals of Neurology · 88
PDF
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
2006 · Jeffrey J. Rohde, Marina A. Pliushchev, et al. · Journal of Medicinal Chemistry · 78
Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance
2020 · Venecia R. Wilson, Xiaochun Lou, et al. · Scientific Reports · 65
PDF
Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors
2006 · Bryan Sorensen, Martin Winn, et al. · Bioorganic & Medicinal Chemistry Letters · 64
The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class
2002 · Richard J. Sciotti, Marina Pliushchev, et al. · Bioorganic & Medicinal Chemistry Letters · 62
Discovery of a Potent Chloroacetamide GPX4 Inhibitor with Bioavailability to Enable Target Engagement in Mice, a Potential Tool Compound for Inducing Ferroptosis In Vivo
2023 · John T. Randolph, Matthew J. O’Connor, et al. · Journal of Medicinal Chemistry · 56
Highlights of the Structure–Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530)
2018 · Rolf Wagner, John T. Randolph, et al. · Journal of Medicinal Chemistry · 56
Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica).
2014 · Allison J Thiede, Kelly D Garcia, et al. · PubMed Central · 46
Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy.
2014 · Elizabeth A Nunamaker, DeAnne F Stolarik, et al. · PubMed Central · 45
Discovery of adamantane ethers as inhibitors of 11β-HSD-1: Synthesis and biological evaluation
2006 · Jyoti R. Patel, Qi Shuai, et al. · Bioorganic & Medicinal Chemistry Letters · 41
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity
2019 · Thomas W. von Geldern, Howard E. Morton, et al. · PLoS neglected tropical diseases · 37
PDF
Adamantane 11-β-HSD-1 inhibitors: Application of an isocyanide multicomponent reaction
2006 · Bryan Sorensen, Jeff Rohde, et al. · Bioorganic & Medicinal Chemistry Letters · 37
Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability
2017 · Steven Cassar, Laura Breidenbach, et al. · Journal of Pharmacological and Toxicological Methods · 33
Assessing the Impact of Endogenously Derived Crystalline Drug on the in Vivo Performance of Amorphous Formulations
2019 · Hitesh S. Purohit, Niraj S. Trasi, et al. · Molecular Pharmaceutics · 32
Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors
2006 · Vince S.C. Yeh, Jyoti R. Patel, et al. · Bioorganic & Medicinal Chemistry Letters · 26
From the Cover: Inhibitors of Nicotinamide Phosphoribosyltransferase Cause Retinal Damage in Larval Zebrafish
2017 · Steven Cassar, Christina Dunn, et al. · Toxicological Sciences · 25
Discovery of orally active butyrolactam 11β-HSD1 inhibitors
2006 · Vince S.C. Yeh, Ravi Kurukulasuriya, et al. · Bioorganic & Medicinal Chemistry Letters · 21
Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530)
2020 · John T. Randolph, Eric A. Voight, et al. · Journal of Medicinal Chemistry · 20
Modeling of Relationships between Pharmacokinetics and Blockade of Agonist-Induced Elevation of Intraurethral Pressure and Mean Arterial Pressure in Conscious Dogs Treated with α1-Adrenoceptor Antagonists
2002 · David G. Witte, Michael E. Brune, et al. · Journal of Pharmacology and Experimental Therapeutics · 19
Expanding the Repertoire for “Large Small Molecules”: Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy Volunteers
2021 · Ahmed Hamed Salem, Zhi-Fu Tao, et al. · Molecular Cancer Therapeutics · 18
PDF
Chemical Renal Denervation in the Rat
2013 · Paul M. Consigny, Dariush Davalian, et al. · CardioVascular and Interventional Radiology · 14
Overcoming Bioavailability Challenges of Dasabuvir and Enabling a Triple-Combination Direct-Acting Antiviral HCV Regimen through a Salt of Very Weak Acid for Oral Delivery
2022 · Shuang Chen, Yi Gao, et al. · Molecular Pharmaceutics · 10
Discovery of fluorobenzimidazole HCV NS5A inhibitors
2016 · John T. Randolph, Charles A. Flentge, et al. · Bioorganic & Medicinal Chemistry Letters · 7
Works count: 41
Citation count: 1,357
H-index: 20
I10-index: 24
Year
Topic
Type